Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06231238 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Balance Acceptance and Commitment Therapy for Long COVID

Study acronym: BalanceACT
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Secondary endpoints: 30 to 32v7
  2. Study completion pushed from Jun 1, 2026 to Aug 1, 2026v6
  3. Primary endpoint(s) modified
    • Primary completion pushed from Apr 14, 2026 to May 30, 2026
    • Secondary endpoints: 27 to 30
    v5
  4. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v4
  5. Secondary endpoints: 26 to 27v3
  6. Phase: Phase 2 to Not applicablev2 Show 6 more changesShow less
    • Trial status: Not Yet Recruiting to Recruiting
    • Primary completion date: Feb 2025 to Apr 14, 2026
    • Study sites: 0 to 1
    • Study completion date: Sep 2025 to Jun 1, 2026
    • Start date changed from estimate of Mar 2024 to Jun 4, 2024
    • Eligibility criteria shortened, about 36 words
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This randomised controlled trial aims to investigate the efficacy of a psychological intervention for long COVID (LC) / post-COVID-19 syndrome (PCS) called Balance Acceptance and Commitment Therapy (Balance ACT). The primary objective of this trial is to investigate whether Balance-ACT improves quality of life over treatment as usual (i.e., self-help leaflet) in people with PCS/LC.
Trial Details
NCT Number NCT06231238
Lead Sponsor King's College London
Conditions
(from sponsor)		 Post-COVID-19 Syndrome, Long COVID
Related terms Post-Acute COVID-19 Syndrome
Enrollment 196 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov